EcoDrugPlus

Ensembl ID : ENSAMXG00000030047
Gene Symbol: RPL10
1 Cross references
408 Possible Orthologues:

Ensembl ID : ENSAMXG00000036690
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSAMXG00000012162
Gene Symbol: -
Cross references: -
298 Possible Orthologues:

Ensembl ID : ENSAMXG00000000543
Gene Symbol: -
Cross references: -
167 Possible Orthologues:

Ensembl ID : ENSAMXG00000020937
Gene Symbol: -
Cross references: -
125 Possible Orthologues:

Ensembl ID : ENSAMXG00000031816
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSAMXG00000029769
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSAMXG00000036461
Gene Symbol: -
Cross references: -
581 Possible Orthologues:

Ensembl ID : ENSAMXG00000020737
Gene Symbol: TP53
1 Cross references
164 Possible Orthologues:

Ensembl ID : ENSAMXG00000043827
Gene Symbol: -
Cross references: -
439 Possible Orthologues:

Ensembl ID : ENSAMXG00000016942
Gene Symbol: THRB
1 Cross references
393 Possible Orthologues:

Ensembl ID : ENSAMXG00000015842
Gene Symbol: RPL24
1 Cross references
322 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).